- Define the rare lipodystrphy syndromes and the subtypes.
- Show that the observation of low leptin in some patients led to an FDA approved treatment.
- Continued work on applying leptin therapy to other metabolic diseases also showed efficacy.
Monday, January 23, 2017 - 5:00pm to 6:00pm
Elif Oral, M.D.
Chicago, IL 60637
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation